Litcius/Paper detail

Design, Synthesis, and In Silico Studies of Novel N-(2-Aminophenyl)-2,3- Diphenylquinoxaline-6-Sulfonamide Derivatives Targeting Receptor- Binding Domain (RBD) of SARS-CoV-2 Spike Glycoprotein and their Evaluation as Antimicrobial and Antimalarial Agents

Falak A. Siddiqui, Sharuk L. Khan, Rajendra Marathe, Nitin Nema

2021Letters in Drug Design & Discovery26 citationsDOI

Topics & Concepts

SulfonamideChemistryCoronavirusGlycoproteinHydrogen bondDocking (animal)In silicoSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)StereochemistryCombinatorial chemistryCoronavirus disease 2019 (COVID-19)BiochemistryPharmacologyMoleculeBiologyMedicineOrganic chemistryInfectious disease (medical specialty)DiseaseNursingPathologyGeneSynthesis and biological activitySynthesis and Biological EvaluationComputational Drug Discovery Methods
Design, Synthesis, and In Silico Studies of Novel N-(2-Aminophenyl)-2,3- Diphenylquinoxaline-6-Sulfonamide Derivatives Targeting Receptor- Binding Domain (RBD) of SARS-CoV-2 Spike Glycoprotein and their Evaluation as Antimicrobial and Antimalarial Agents | Litcius